NF-κB: arresting a major culprit in cancer
- 1 June 2002
- journal article
- review article
- Published by Elsevier in Drug Discovery Today
- Vol. 7 (12) , 653-663
- https://doi.org/10.1016/s1359-6446(02)02309-7
Abstract
No abstract availableKeywords
This publication has 80 references indexed in Scilit:
- NF-κB in cancer: from innocent bystander to major culpritNature Reviews Cancer, 2002
- NSAIDs and Gastrointestinal Cancer PreventionDrugs, 2002
- Inhibition of NF-κB sensitizes human pancreatic carcinoma cells to apoptosis induced by etoposide (VP16) or doxorubicinOncogene, 2001
- Constitutive activation of IκB kinase α and NF-κB in prostate cancer cells is inhibited by ibuprofenOncogene, 1999
- Aberrant rel/nfkb genes and activity in human cancerOncogene, 1999
- Regulation of NF-κB RelA Phosphorylation and Transcriptional Activity by p21 and Protein Kinase Cζ in Primary Endothelial CellsJournal of Biological Chemistry, 1999
- The TRAIL to an anti-cancer agentDrug Resistance Updates, 1999
- Tumour necrosis factor and cancerProgress in Growth Factor Research, 1992
- The inhibition of phosphatidylinositol 3-kinase by quercetin and analogsBiochemical and Biophysical Research Communications, 1992
- Tumors: Wounds That Do Not HealNew England Journal of Medicine, 1986